IP Library Granted Patent US 9,649,478
Granted Patent B2
US 9,649,478 · App. 14/247,057 · Granted May 16, 2017

Balloon catheter systems for delivery of dry drug delivery vesicles to a vessel in the body

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,649,478
App. No.
14/247,057
Granted
May 16, 2017
Kind
B2
Abstract

Devices and methods for balloon delivery of rapamycin and other hydrophobic compounds to the wall of blood vessels. Balloon catheters, such as those used for balloon angioplasty, are modified with the addition of a reservoir of dry micelles, disposed at a suitable location within the balloon or catheter. The reservoir may be installed within the angioplasty balloon, within a lumen in communication with the angioplasty balloon, either as a loose or packed powder or as a film coating. The micelle preparation is reconstituted and the micelles are mobilized when the aqueous solution used to inflate the balloons is injected into the catheter. The micelles are infused into tissue surrounding the balloon when pressurized fluid within the balloon leaks through the wall of the balloon.

Claims (40)

1. A method of treating a lesion in a blood vessel of a patient comprising:

providing balloon catheter system comprising:

a catheter body characterized by a distal portion and a proximal portion;

a first, outer, balloon disposed on the distal portion of the catheter body, said first, outer, balloon having a porous wall portion;

a reservoir of lyophilized micelles with rapamycin encapsulated in the micelles, said reservoir disposed within the first, outer, balloon

a reservoir of aqueous solution suitable for mobilizing the micelles within the micelle reservoir;

a first injection port disposed on the proximal portion of the catheter body; and

a first lumen communicating from the first injection port to the first, outer, balloon;

inserting the distal portion of the catheter body into the blood vessel such that the first, outer, balloon is disposed near the lesion; and thereafter

filling the first, outer, balloon with the aqueous solution to wet and mobilize the micelles;

pressurizing the first, outer, balloon to force the micelles through the porous wall portion of the first, outer, balloon into the blood vessel.

2. The method of claim 1 further comprising the steps of:

providing the balloon catheter system with a second, inner, balloon disposed on the distal portion of the catheter body, within the first, outer, balloon, defining an inter-balloon space between the first, outer, balloon and the second, inner, balloon; a second injection port disposed on the proximal portion of the catheter body; a second lumen communicating from the second injection port to the second, inner, balloon; wherein the micelle reservoir is disposed in the inter-balloon space between the first, outer, balloon and the second, inner, balloon; and

after filling the first, outer, balloon with the aqueous solution to wet and mobilize the micelles, inflating the second, inner, balloon to accomplish the step of pressurizing the first, outer, balloon to force the micelles through the porous wall portion of the first, outer, balloon into the blood vessel.

3. The method of claim 1 further comprising the steps of:

pressurizing the first, outer, balloon with the aqueous solution to wet and mobilize the micelles to perform angioplasty within the blood vessel.

4. The method of claim 2 further comprising the steps of:

pressurizing the first, outer, balloon with the aqueous solution to wet and mobilize the micelles to perform angioplasty within the blood vessel.

5. The method of claim 2 further comprising the steps of:

pressurizing the second, inner, balloon to perform angioplasty within the blood vessel.

6. The method of claim 2 further comprising the steps of:

pressurizing the first, outer, balloon to perform angioplasty within the blood vessel, and thereafter inflating the second, inner, balloon to pressurize the first, outer, balloon and thereby force micelles through the porous wall portion of the first, outer, balloon.

7. The method of claim 2 further comprising the steps of:

pressurizing the second, inner, balloon to perform angioplasty within the blood vessel, and thereafter deflating the second, inner, balloon and performing the step of filling the first outer balloon to wet and mobilize the micelles, and thereafter inflating the second, inner, balloon to pressurize the first, outer, balloon and thereby force the micelles through the porous wall portion of the first, outer, balloon.

8. The method of claim 2 further comprising the steps of:

providing the second, inner, balloon with a porous wall portion and the reservoir of lyophilized micelles disposed in the inter-balloon space defined between the first, outer, balloon and the second, inner, balloon;

pressurizing the second, inner, balloon with fluid from the reservoir of aqueous solution to perform angioplasty within the blood vessel, thereby forcing flow from the reservoir of aqueous solutions through the second, inner, balloon porous wall section and into the inter-balloon space to wet the micelle reservoir disposed in the inter-balloon space and flush the micelles through the porous wall portion of the first, outer, balloon.

9. The method of claim 1 , wherein:

the porous wall portion of the first, outer, balloon has pores with a diameter of 0.1 to 5 microns;

the step of wetting and mobilizing the micelles is performed such that the micelles have a particle size of 40 to 250 nm; and

the step of pressuring the first, outer balloon, is performed to a pressure of 6 to 12 atmospheres.

10. The method of claim 9 further comprising the steps of:

providing the balloon catheter system with a second, inner, balloon disposed on the distal portion of the catheter body, within the first, outer, balloon, defining an inter-balloon space between the first, outer, balloon and the second, inner, balloon; a second injection port disposed on the proximal portion of the catheter body; a second lumen communicating from the second injection port to the second, inner, balloon; wherein the micelle reservoir is disposed in the inter-balloon space between the first, outer, balloon and the second, inner, balloon; and

after filling the first, outer, balloon with the aqueous solution to wet and mobilize the micelles, inflating the second, inner, balloon to accomplish the step of pressurizing the first, outer, balloon to force the micelles through the porous wall portion of the first, outer, balloon into the blood vessel.

11. The method of claim 9 further comprising the steps of:

pressurizing the first, outer, balloon to perform angioplasty within the blood vessel.

12. The method of claim 10 further comprising the steps of:

pressurizing the first, outer, balloon to perform angioplasty within the blood vessel.

13. The method of claim 10 further comprising the steps of:

pressurizing the first, outer, balloon to perform angioplasty within the blood vessel, and thereafter inflating the second, inner, balloon to pressurize the first, outer, balloon and thereby force micelles through the porous wall portion of the first, outer, balloon.

Assignments (9)
SECURITY INTEREST Recorded Aug 7, 2025
From: ORCHESTRA BIOMED HOLDINGS, INC.; ORCHESTRA BIOMED, INC.; BACKBEAT MEDICAL, LLC; CALIBER THERAPEUTICS, LLC
To: MEDTRONIC, INC.
Reel/Frame 072341/0075 →
SECURITY INTEREST Recorded Aug 4, 2025
From: ORCHESTRA BIOMED HOLDINGS, INC.; ORCHESTRA BIOMED, INC.; BACKBEAT MEDICAL, LLC; CALIBER THERAPEUTICS, LLC
To: LIGAND PHARMACEUTICALS, INC.
Reel/Frame 072359/0219 →
SECURITY INTEREST Recorded Nov 6, 2024
From: ORCHESTRA BIOMED HOLDINGS, INC.; ORCHESTRA BIOMED, INC.; CALIBER THERAPEUTICS, LLC; BACKBEAT MEDICAL, LLC; FREEHOLD SURGICAL, LLC
To: HERCULES CAPITAL, INC.
Reel/Frame 069312/0758 →
RELEASE OF IP SECURITY INTEREST Recorded Oct 9, 2023
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
To: ORCHESTRA BIOMED, INC.; CALIBER THERAPEUTICS, LLC; BACKBEAT MEDICAL, LLC; FREEHOLD SURGICAL, LLC; ACCELERATED TECHNOLOGIES, INC.
Reel/Frame 065192/0001 →
SECURITY AGREEMENT Recorded Jun 6, 2022
From: ORCHESTRA BIOMED, INC.; CALIBER THERAPEUTICS, LLC; BACKBEAT MEDICAL, LLC; FREEHOLD SURGICAL, LLC; ACCELERATED TECHNOLOGIES, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND, L.P., AS AGENT
Reel/Frame 060286/0021 →
ENTITY CONVERSION Recorded Feb 12, 2020
From: CALIBER THERAPEUTICS, INC.
To: CALIBER THERAPEUTICS, LLC
Reel/Frame 051911/0718 →
RELEASE OF SECURITY INTEREST Recorded Jun 13, 2017
From: ORCHESTRA MEDICAL VENTURES II, L.P.
To: CALIBER THERAPEUTICS, INC.
Reel/Frame 042695/0937 →
SECURITY INTEREST Recorded Jan 20, 2016
From: CALIBER THERAPEUTICS, INC.
To: ORCHESTRA MEDICAL VENTURES II, L.P.; THE PEIERLS GROUP; ORCHESTRA CALIBER CO-INVESTMENT PARTNERS, LLC; ASCENT BIOMEDICAL VENTURES II, LP; ASCENT BIOMEDICAL VENTURES SYNECOR, LP
Reel/Frame 037532/0524 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2015
From: BAUMBACH, WILLIAM R., PH.D; SHERMAN, DARREN R.; BURGERMEISTER, ROBERT
To: CALIBER THERAPEUTICS, INC.
Reel/Frame 035643/0779 →